Exact Mass: 569.1791312
Exact Mass Matches: 569.1791312
Found 193 metabolites which its exact mass value is equals to given mass value 569.1791312
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Decarbamoylnovobiocin
A hydroxycoumarin that is novobiocin lacking the carbamoyl group from position 3 on the hexose ring.
Aklavin
D000970 - Antineoplastic Agents D007155 - Immunologic Factors
Firsocostat
Aklavin
Emricasan
Guanosine, 2'-deoxy-N-(7,8,9,10-tetrahydro-7,8,9-trihydroxybenzo(a)pyren-10-yl)-
Astin C
Astin C (Asterin) is a cyclic pentapeptide with anticancer and anti-inflammatory properties[1]. Astin C (Asterin) is a cyclic pentapeptide with anticancer and anti-inflammatory properties[1]. Astin C (Asterin) is a cyclic pentapeptide with anticancer and anti-inflammatory properties[1].
C25H33Cl2N5O6_17,18-Dichloro-3,13-diethyl-6-(hydroxymethyl)-9-phenyldodecahydropyrrolo[1,2-d][1,4,7,10,13]pentaazacyclohexadecine-1,4,7,11,14(8H)-pentone
Cys Asp Phe Trp
Cys Asp Trp Phe
Cys Glu Arg Tyr
C23H35N7O8S (569.2267710000001)
Cys Glu Tyr Arg
C23H35N7O8S (569.2267710000001)
Cys Phe Asp Trp
Cys Phe Trp Asp
Cys Met Met Trp
Cys Met Trp Met
Cys Arg Glu Tyr
C23H35N7O8S (569.2267710000001)
Cys Arg Tyr Glu
C23H35N7O8S (569.2267710000001)
Cys Trp Asp Phe
Cys Trp Phe Asp
Cys Trp Met Met
Cys Tyr Glu Arg
C23H35N7O8S (569.2267710000001)
Cys Tyr Arg Glu
C23H35N7O8S (569.2267710000001)
Asp Cys Phe Trp
Asp Cys Trp Phe
Asp Phe Cys Trp
Asp Phe Trp Cys
Asp Ser Trp Tyr
Asp Ser Tyr Trp
Asp Trp Cys Phe
Asp Trp Phe Cys
Asp Trp Ser Tyr
Asp Trp Tyr Ser
Asp Tyr Ser Trp
Asp Tyr Trp Ser
Glu Cys Arg Tyr
C23H35N7O8S (569.2267710000001)
Glu Cys Tyr Arg
C23H35N7O8S (569.2267710000001)
Glu Met Gln Tyr
Glu Met Tyr Gln
Glu Gln Met Tyr
Glu Gln Tyr Met
Glu Arg Cys Tyr
C23H35N7O8S (569.2267710000001)
Glu Arg Tyr Cys
C23H35N7O8S (569.2267710000001)
Glu Tyr Cys Arg
C23H35N7O8S (569.2267710000001)
Glu Tyr Met Gln
Glu Tyr Gln Met
Glu Tyr Arg Cys
C23H35N7O8S (569.2267710000001)
Phe Cys Asp Trp
Phe Cys Trp Asp
Phe Asp Cys Trp
Phe Asp Trp Cys
Phe Trp Cys Asp
Phe Trp Asp Cys
Met Cys Met Trp
Met Cys Trp Met
Met Glu Gln Tyr
Met Glu Tyr Gln
Met Met Cys Trp
Met Met Trp Cys
Met Gln Glu Tyr
Met Gln Tyr Glu
Met Trp Cys Met
Met Trp Met Cys
Met Tyr Glu Gln
Met Tyr Gln Glu
Gln Glu Met Tyr
Gln Glu Tyr Met
Gln Met Glu Tyr
Gln Met Tyr Glu
Gln Tyr Glu Met
Gln Tyr Met Glu
Arg Cys Glu Tyr
C23H35N7O8S (569.2267710000001)
Arg Cys Tyr Glu
C23H35N7O8S (569.2267710000001)
Arg Glu Cys Tyr
C23H35N7O8S (569.2267710000001)
Arg Glu Tyr Cys
C23H35N7O8S (569.2267710000001)
Arg Tyr Cys Glu
C23H35N7O8S (569.2267710000001)
Arg Tyr Glu Cys
C23H35N7O8S (569.2267710000001)
Ser Asp Trp Tyr
Ser Asp Tyr Trp
Ser Trp Asp Tyr
Ser Trp Tyr Asp
Ser Tyr Asp Trp
Ser Tyr Trp Asp
Trp Cys Asp Phe
Trp Cys Phe Asp
Trp Cys Met Met
Trp Asp Cys Phe
Trp Asp Phe Cys
Trp Asp Ser Tyr
Trp Asp Tyr Ser
Trp Phe Cys Asp
Trp Phe Asp Cys
Trp Met Cys Met
Trp Met Met Cys
Trp Ser Asp Tyr
Trp Ser Tyr Asp
Trp Tyr Asp Ser
Trp Tyr Ser Asp
Tyr Cys Glu Arg
C23H35N7O8S (569.2267710000001)
Tyr Cys Arg Glu
C23H35N7O8S (569.2267710000001)
Tyr Asp Ser Trp
Tyr Asp Trp Ser
Tyr Glu Cys Arg
C23H35N7O8S (569.2267710000001)
Tyr Glu Met Gln
Tyr Glu Gln Met
Tyr Glu Arg Cys
C23H35N7O8S (569.2267710000001)
Tyr Met Glu Gln
Tyr Met Gln Glu
Tyr Gln Glu Met
Tyr Gln Met Glu
Tyr Arg Cys Glu
C23H35N7O8S (569.2267710000001)
Tyr Arg Glu Cys
C23H35N7O8S (569.2267710000001)
Tyr Ser Asp Trp
Tyr Ser Trp Asp
Tyr Trp Asp Ser
Tyr Trp Ser Asp
5-O-[BIS(4-METHOXYPHENYL)PHENYLMETHYL]-ADENOSINE
5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-adenosine is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1].
Emricasan
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2,3,5-Tri-O-benzyl-D-arabinofuranose 1-(4-nitrobenzoate)
Motesanib diphosphate
C22H29N5O9P2 (569.1440444000001)
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
Bosentan hydrate
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D065128 - Endothelin Receptor Antagonists C28313 - Endothelin Receptor Antagonist Bosentan hydrate is a competitive and dual antagonist of endothelin-1 (ET) for the ETA and ETB receptors with Ki of 4.7 nM and 95 nM in human SMC, respectively.
2,3,5-TRI-O-BENZYL-1-O-(4-NITROBENZOYL)-D-ALPHA-ARABINOFURANOSE
TERT-BUTYL 4-((6-(2-(QUINOXALINE-2-CARBOXAMIDO)PHENYL)IMIDAZO[2,1-B]THIAZOL-3-YL)METHYL)PIPERAZINE-1-CARBOXYLATE
C30H31N7O3S (569.2208976000001)
Haloperidol-1-hydroxy-2-D-glucuronide
C27H33ClFNO9 (569.1827770000001)
3(2H)-Benzoxazolepropanesulfonic acid, 2-[4-(1,3-dibutyltetrahydro-4,6-dioxo-2-thioxo-5(2H)-pyrimidinylidene)-2-butenylidene]-, sodium salt
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes D003879 - Dermatologic Agents
Firsocostat
D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor Firsocostat (ND-630; GS-0976; NDI-010976) is an acetyl-CoA carboxylase (ACC) inhibitor; inhibits human ACC1 and ACC2 with IC50 values of 2.1 and 6.1 nM, respectively.
(1R,2R,4S)-2-ethyl-2,7-dihydroxy-1-(methoxycarbonyl)-6,11-dioxo-4-{[2,3,6-trideoxy-3-(dimethylazaniumyl)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracen-5-olate
Lactonamycin
C28H27NO12 (569.1533182000001)
An organic heterohexacyclic compound isolated from the culture broth of Streptomyces rishiriensis. It is an antibiotic with antibacterial activity.
{3-[(6-(anilinocarbonyl)-5-(4-ethoxyphenyl)-7-methyl-3-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidin-2(3H)-ylidene)methyl]phenoxy}acetic acid
C31H27N3O6S (569.1620482000001)
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
(4-fluorophenyl)-[(1R)-1-(hydroxymethyl)-7-methoxy-1-thiophen-2-ylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanone
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
(4-fluorophenyl)-[(1S)-1-(hydroxymethyl)-7-methoxy-1-thiophen-2-ylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanone
aclacinomycin T zwitterion
A zwitterion obtained by transfer of a proton from the 5-hydroxy to the tertiary amino group of aclacinomycin T. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl group
The group obtained by removal of the anomeric hydroxyl group from beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosamine.
Aclacinomycin T
An anthracycline that is aklavinone having an alpha-L-rhodosaminyl residue attached at position 4 via a glycosidic linkage.
(2r)-1',5,8,9,9',10-hexahydroxy-7-methoxy-3'-[(1e,3e)-penta-1,3-dien-1-yl]-6',7'-dihydrospiro[anthracene-2,8'-cyclopenta[g]isoquinoline]-1,3,4-trione
2,9-dihydroxy-15-[(5-hydroxy-6-methyloxan-2-yl)oxy]-18-methoxy-6-methyl-17,21-dioxa-6-azahexacyclo[11.10.0.0³,¹¹.0⁴,⁸.0¹⁵,²².0¹⁸,²²]tricosa-1,3,8,10,12-pentaene-7,14,20,23-tetrone
C28H27NO12 (569.1533182000001)
(3s,6s,9r,13s,17r,18s,18ar)-17,18-dichloro-3,13-diethyl-1,4,7,11-tetrahydroxy-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one
1',5,8,9,9',10-hexahydroxy-7-methoxy-3'-(penta-1,3-dien-1-yl)-6',7'-dihydrospiro[anthracene-2,8'-cyclopenta[g]isoquinoline]-1,3,4-trione
(3r,6r,13r,17s,18r,18as)-17,18-dichloro-3,13-diethyl-1,4,7,11-tetrahydroxy-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one
n-(6-{[(1s,3s)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1h-tetracen-1-yl]oxy}-3-hydroxy-2-methyloxan-4-yl)ethanimidic acid
methyl (1r,2r,4s)-4-{[(2s,4s,5r,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
(1r,2r,5s,6r,7r,8s,9s,12r)-5,8-bis(acetyloxy)-12-(furan-3-carbonyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate
(4s,5s,6s)-4,5-dihydroxy-n-[(3s)-2-hydroxy-4,5,6,7-tetrahydro-3h-azepin-3-yl]-6-[(r)-[(2s,3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl](c-hydroxycarbonimidoyl)methoxy]-5,6-dihydro-4h-pyran-2-carboximidic acid
5,8-bis(acetyloxy)-12-(furan-3-carbonyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate
(4s,5s,6s)-6-[(r)-[(2s,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl](c-hydroxycarbonimidoyl)methoxy]-4,5-dihydroxy-n-[(3s,7r)-2-hydroxy-7-methyl-4,5,6,7-tetrahydro-3h-azepin-3-yl]-5,6-dihydro-4h-pyran-2-carboximidic acid
17,18-dichloro-3,13-diethyl-1,4,7,11-tetrahydroxy-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one
(15s,18s)-2,9-dihydroxy-15-{[(2s,5s,6s)-5-hydroxy-6-methyloxan-2-yl]oxy}-18-methoxy-6-methyl-17,21-dioxa-6-azahexacyclo[11.10.0.0³,¹¹.0⁴,⁸.0¹⁵,²².0¹⁸,²²]tricosa-1,3,8,10,12-pentaene-7,14,20,23-tetrone
C28H27NO12 (569.1533182000001)